The ongoing battle against COVID-19 is inducing researchers to come up with new innovations to increase the efficiency of the virus’ detection, including the detection of antibody titer post-exposure. Researchers of IPB University are not excluded in this effort and has successfully invented two unique innovations for this exact purpose. The innovations are called the Inventpro Reverse Transcriptase (RT) Enzyme and the IPB ELISA Kit: COVID-19 Antibody. These innovations were created with the aim of increasing awareness of vaccination against the COVID-19 virus by providing affordable methods of evaluating the vaccines’ efficacy using the antibody detection method of ELISA as well as RT-PCR.